Literature DB >> 17235089

What have we learnt from Vioxx?

Harlan M Krumholz1, Joseph S Ross, Amos H Presler, David S Egilman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17235089      PMCID： PMC1779871          DOI： 10.1136/bmj.39024.487720.68

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

Authors:  Christopher P Cannon; Sean P Curtis; Garret A FitzGerald; Henry Krum; Amarjot Kaur; James A Bolognese; Alise S Reicin; Claire Bombardier; Michael E Weinblatt; Désirée van der Heijde; Erland Erdmann; Loren Laine
Journal:  Lancet       Date:  2006-11-18       Impact factor: 79.321
  1 in total
  54 in total

1.  Separating the wheat from the chaff: essential information in therapeutics.

Authors:  Roser Llop; Montse Bosch; Albert Figueras; Joan-Ramon Laporte
Journal:  Eur J Clin Pharmacol       Date:  2011-10-21       Impact factor: 2.953

2.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications.

Authors:  Joseph S Ross; Harlan M Krumholz
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

3.  Early termination of drug trials.

Authors:  Gorm Boje Jensen; John Hampton
Journal:  BMJ       Date:  2007-02-17

4.  Principles for the ethical analysis of clinical and translational research.

Authors:  Jonathan A L Gelfond; Elizabeth Heitman; Brad H Pollock; Craig M Klugman
Journal:  Stat Med       Date:  2011-07-12       Impact factor: 2.373

5.  Medicine. Moving toward transparency of clinical trials.

Authors:  Deborah A Zarin; Tony Tse
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

6.  Has the hunt for conflicts of interest gone too far? Yes.

Authors:  Thomas P Stossel
Journal:  BMJ       Date:  2008-03-01

7.  Direct to consumer advertising of drugs in Europe.

Authors:  Nicola Magrini; Maria Font
Journal:  BMJ       Date:  2007-09-15

8.  Rofecoxib-Induced Deleterious Effects Escape Detection by Organismal Performance Assays.

Authors:  Shannon M Gaukler; James S Ruff; Linda C Morrison; Wayne Potts
Journal:  J Pharm Negat Results       Date:  2016-02-19

9.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.

Authors:  Laurence J Hirsch
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

10.  No short-cut in assessing trial quality: a case study.

Authors:  Karim F Hirji
Journal:  Trials       Date:  2009-01-07       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.